首页> 外文期刊>Journal of infusion nursing: the official publication of the Infusion Nurses Society >Risk of Patient Harm Related to Unnecessary Dilution of Ready-to-Administer Prefilled Syringes A Literature Review
【24h】

Risk of Patient Harm Related to Unnecessary Dilution of Ready-to-Administer Prefilled Syringes A Literature Review

机译:患者危害风险与不必要的即时稀释的准备施用预填充注射器进行了文献综述

获取原文
获取原文并翻译 | 示例
       

摘要

Unnecessary dilution of ready-to-administer (RTA) syringes could increase the risk of patient harm attributed to errors related to incorrect dose, improper labeling, and the potential for microbial contamination. Although published guidelines endorse the use of commercially available RTA syringes, recent surveys indicate that best practices are not always implemented. The purpose of this article is to review the existing literature and to assess the incidence and nature of errors related to the unnecessary dilution of RTA intravenous (IV) push medications in the inpatient clinical setting. The PubMed database was searched to identify studies of errors related to the use of RTA syringes for IV push medications within the last 10 years. An additional search was conducted using other search engines to identify relevant articles in the grey literature. This literature review concludes that unnecessary dilution of IV push medication in RTA syringes is an unsafe practice that occurs routinely. This practice increases the risk of patient harm through errors related to incorrect dose, improper labeling of syringes, and the potential for microbial contamination of the product. Greater awareness of the risks associated with unnecessary dilution of RTA syringes is still needed to eliminate this unsafe IV push medication administration practice and to thereby further improve outcomes.
机译:不必要的即时施用(RTA)注射器的稀释可能会增加患者危害的风险,这些危害造成与不正确的剂量,不正确标记的误差和微生物污染的可能性。虽然已发表的指导方针赞同商业上可获得的RTA注射器,但最近的调查表明并不总是实施最佳实践。本文的目的是审查现有的文献,并评估与在本文临床临床环境中不必要的RTA静脉内(IV)推药相关的误差的发生率和性质。搜索了PUBMED数据库,以识别与在过去10年内使用RTA注射器使用RTA注射器相关的误差的研究。使用其他搜索引擎进行额外的搜索,以识别灰色文献中的相关文章。该文献综述得出结论,在RTA注射器中不必要的稀释药物稀释药物是常规发生的不安全的做法。这种做法提高了患者伤害的风险,通过与不正确的剂量,不当标记的注射器相关的误差以及产品的微生物污染的可能性。仍然需要更高意识与不必要的RTA注射器相关的风险,以消除这种不安全的IV推送药物管理实践,从而进一步改善结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号